WAMP-Based Part B Reimbursement For Five Drugs Could Save $67 Mil. – OIG
Executive Summary
The HHS Office of Inspector General (OIG) contends that reimbursement for five Medicare Part B drugs is too high relative to their market prices and recommends that CMS lower payment levels for them